|
The DuPage Federation on Human Services Reform, in partnership with the DuPage County Health Department, completed an environmental scan of tobacco retailers across DuPage County. Their aims were threefold:
1. Assess the distribution and density of tobacco retailers;
2. Document the types and range of tobacco, THC, and kratom-based products available
3. Provide recommendations to help the DuPage County Health Department strategically focus prevention and advocacy resources.
DuPage Federation staff used registered cigarette and tobacco retailer data from the Illinois Department of Revenue to assess retailer density by municipality and countywide. U.S. Census data on municipal geography and population, coupled with Impact DuPage data on municipal rates of adult smoking and smoking-cessation attempts, provided contextual information regarding community-level risk and tobacco retailer density.
Twenty DuPage County municipalities were selected based on retailer density, population risk factors, and geographic distribution. Between April and June 2026, staff visited 200 registered tobacco retailers to obtain a sufficiently robust and geographically representative sample. A structured assessment rubric, informed by Prevention First and other environmental scan toolkits, was used to document the types and range of tobacco, THC, and kratom products sold, number, type and location of advertisements, product placement, discounts and price promotions, proximity to sensitive locations such as schools and public libraries, and age-of-sale signage.
The scan identified several significant public health concerns:
- All retailer types, including gas stations, pharmacies, grocery stores, and smoke/vape shops, regularly sold tobacco products,
- Nearly all smoke/vape shops sold a broad range of tobacco, THC, and kratom products.
- More than one in five gas stations and one in ten convenience stores sold kratom, increasing its accessibility beyond specialty vape/smoke shops.
- Retailers used strong marketing strategies that may appeal to youth and other vulnerable audiences, coupled with potentially misleading or confusing product claims and dosage information that may amplify risk.
Recommendations from this project will be used to guide policy, public awareness, education, treatment, and recovery efforts. For more information, please contact Mimi Doll, PhD. You can download the report here.
|